Skip to content

Prospect Capital PSEC Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Blue Owl Capital logo
Blue Owl CapitalOBDC
Bain Capital Specialty Finance logo
Bain Capital Specialty FinanceBCSF
Goldman Sachs BDC logo
Goldman Sachs BDCGSBD
MidCap Financial Investment Corporation logo
MidCap Financial Investment CorporationMFIC
Golub Capital logo
Golub CapitalGBDC
Capital Southwest logo
Capital SouthwestCSWC

Other financials

Income statement

See full
Net income-$648.7M-228%
EPS (diluted)$0.05+113%

Balance sheet

See full
Cash & equivalents$34.6M-36.5%
Total debt$2.1B+4.1%
Total equity$3.0B-9.0%
Total assets$6.4B-8.8%

Cash flow

See full
Operating cash flow$195.7M+149%

Valuation

See full
Market cap$1.11B-21.0%
Enterprise value$3.19B-5.8%

Returns & leverage

See full
Return on equity21.5%+14.9pp
Debt / equity0.7×+0.1×

Where this comes from

Reported directly by Prospect Capital in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Prospect Capital’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prospect Capital's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prospect Capital's common stock, shares authorized (in shares)?
Prospect Capital (PSEC) reported common stock, shares authorized (in shares) of $1.17B in Q1 2026.
How has Prospect Capital's common stock, shares authorized (in shares) changed year-over-year?
Prospect Capital's common stock, shares authorized (in shares) increased by 1.3% year-over-year, from $1.15B to $1.17B.
What is the long-term trend for Prospect Capital's common stock, shares authorized (in shares)?
Over 3 years (2022 to 2025), Prospect Capital's common stock, shares authorized (in shares) has grown at a -13.1% compound annual growth rate (CAGR), from $1.77B to $1.16B.